Inventor · disambiguated record
Donna T. Ward
Also filed as: WARD DONNA T
18 granted patents·44 pending applications·688 citations·filing 1999–2024
95Inventor score
Files withISIS PHARMACEUTICALS INC27VOYAGER THERAPEUTICS INC8TARVEDA THERAPEUTICS INC5BENNETT C F4ALNYLAM PHARMACEUTICALS INC3
Top patents by PatentIndex Score
62 records- 0199US7217572B2Modulation of HIF1α and HIF2α expressionISIS PHARMACEUTICALS INC·Filed 2003·Granted May 15, 2007·139 cites·18 claims
- 0299US6287860B1Antisense inhibition of MEKK2 expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Sep 11, 2001·334 cites·14 claims
- 0398US7144999B2Modulation of hypoxia-inducible factor 1 alpha expressionISIS PHARMACEUTICALS INC·Filed 2002·Granted Dec 5, 2006·115 cites·24 claims
- 0496US11326182B2Compositions for the treatment of diseaseVOYAGER THERAPEUTICS INC·Filed 2017·Granted May 10, 2022·18 cites·24 claims
- 0590US6448080B1Antisense modulation of WRN expressionISIS PHARMACEUTICALS INC·Filed 2001·Granted Sep 10, 2002·21 cites·27 claims
- 0682US6426221B1Antisense modulation of RIP2 expressionISIS PHARMACEUTICALS INC·Filed 2001·Granted Jul 30, 2002·8 cites·26 claims
- 0781US10190118B2Methods and compositions for treating insectsALNYLAM PHARMACEUTICALS INC·Filed 2016·Granted Jan 29, 2019·3 cites·16 claims
- 0878US6444466B1Antisense modulation of helicase-moi expressionISIS PHARMACEUTICALS INC·Filed 2001·Granted Sep 3, 2002·4 cites·26 claims
- 0976US6399378B1Antisense modulation of RECQL2 expressionISIS PHARMACEUTICALS INC·Filed 2001·Granted Jun 4, 2002·3 cites·26 claims
- 1073US7709453B2Modulation of the RNA interference pathwayISIS PHARMACEUTICALS INC·Filed 2004·Granted May 4, 2010·2 cites·51 claims
- 1173US7427470B2Antisense modulation of helicase-moi expressionISIS PHARMACEUTICALS INC·Filed 2002·Granted Sep 23, 2008·2 cites·13 claims
- 1272US6436706B1Antisense inhibitor of RECQL4 expressionISIS PHARMACEUTICALS INC·Filed 2001·Granted Aug 20, 2002·2 cites·27 claims
- 1371US2025090197A1Cannula system and use thereofVOYAGER THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1470US2022389449A1Compositions for the treatment of diseaseVOYAGER THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1568US2022395544A1Compositions for the treatment of diseaseVOYAGER THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1666US6168950B1Antisense modulation of MEKK1 expressionISIS PHARMACEUTICALS INC·Filed 1999·Granted Jan 2, 2001·19 cites·23 claims
- 1765US8513400B2Modulation of HIF1α and HIF2α expressionWARD DONNA T·Filed 2009·Granted Aug 20, 2013·0 cites·18 claims
- 1863US2020339990A1RNAi CONJUGATES, PARTICLES AND FORMULATIONS THEREOFTARVEDA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1962US2007020679A1Modulation of HIF1alpha and HIF2alpha expressionISIS PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 2061US11299751B2Compositions for the treatment of diseaseVOYAGER THERAPEUTICS INC·Filed 2017·Granted Apr 12, 2022·0 cites·20 claims
- 2161US2019233815A1Methods and compositions for treating insectsALNYLAM PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2258US2003083302A1Antisense modulation of RECQL5 expressionFiled 2002·Application pending·0 cites
- 2356US2022333133A1Vectorized editing of nucleic acids to correct overt mutationsVOYAGER THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2456US2003114412A1Antisense modulation of RECQL5 expressionFiled 2002·Application pending·0 cites
- 2555US2005153925A1Compositions and their uses directed to transferasesFiled 2004·Application pending·0 cites
- 2654US2005164254A1Compositions and their uses directed to metabolic proteinsFiled 2004·Application pending·0 cites
- 2754US2005142581A1Microrna as ligands and target moleculesFiled 2004·Application pending·0 cites
- 2854US2015011614A1Methods and compositions for treating insectsALNYLAM PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 2954US2005186594A1Compositions and their uses directed to cell growth and maintenance proteinsFiled 2004·Application pending·0 cites
- 3053US6165728AAntisense modulation of NCK-2 expressionISIS PHARMACEUTICALS INC·Filed 1999·Granted Dec 26, 2000·8 cites·10 claims
- 3153US2023075314A1VECTORIZED ANTIBODIES (vAb) AND USES THEREOFVOYAGER THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3253US2021361318A1Cannula system and use thereofVOYAGER THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3353US2005075299A1Antisense modulation of wrn espressionFiled 2002·Application pending·0 cites
- 3452US2004033976A1Antisense modulation of mekk3 expressionFiled 2001·Application pending·0 cites
- 3551US2018273948A1RNAi CONJUGATES, PARTICLES AND FORMULATIONS THEREOFTARVEDA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 3650US2003144242A1Antisense modulation of MEKK4 expressionFiled 2003·Application pending·0 cites
- 3750US2004224912A1Modulation of PAI-1 mRNA-binding protein expressionISIS PHARMACEUTICALS INC·Filed 2003·Application pending·0 cites
- 3850US2004002467A1Antisense modulation of ADAM12 expressionISIS PHARMACEUTICALS INC·Filed 2002·Application pending·0 cites
- 3949US2004110151A1Modulation of sentrin-2 expressionISIS PHARMACEUTICALS INC·Filed 2002·Application pending·0 cites
- 4049US2004101857A1Modulation of cytokine-inducible kinase expressionISIS PHARMACEUTICALS INC·Filed 2002·Application pending·0 cites
- 4148US2004101848A1Modulation of glucose transporter-4 expressionISIS PHARMACEUTICALS INC·Filed 2002·Application pending·0 cites
- 4247US6165790AAntisense modulation of PI3 kinase p55 gamma expressionISIS PHARMACEUTICALS INC·Filed 1999·Granted Dec 26, 2000·10 cites·23 claims
- 4347US2004185479A1Modified oligonucleotides for use in gene modulationFiled 2004·Application pending·0 cites
- 4447US2003225015A1Antisense modulation of Rb2/p130 expressionISIS PHARMACEUTICALS INC·Filed 2002·Application pending·0 cites
- 4546US2003105042A1Antisense modulation of EIF2C1 expressionISIS PHARMACEUTICALS INC·Filed 2001·Application pending·0 cites
- 4645US2003100522A1Antisense modulation of ribonuclease L expressionISIS PHARMACEUTICALS INC·Filed 2001·Application pending·0 cites
- 4745US2003134809A1Antisense modulation of ABC transporter MHC 1 expressionISIS PHARMACEUTICALS INC·Filed 2001·Application pending·0 cites
- 4845US2003087855A1Antisense modulation of protein kinase R expressionISIS PHARMACEUTICALS INC·Filed 2001·Application pending·0 cites
- 4945US2005215504A1Antisense modulation of sterol regulatory element-binding protein-1 expressionBENNETT C F·Filed 2004·Application pending·0 cites
- 5044US2005182015A1Antisense modulation of EIF2C1 expressionFiled 2005·Application pending·0 cites
Showing the top 50 of 62 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Donna T. Ward files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →